Independent
Tenure on this board
1.4 yrs
Also a director at
Pelagos Insurance Capital Ltd (PLGO)
Meeting calendar
GL · Annual meeting · Thursday, April 30, 2026
Globe Life Inc
12 nominees · 4 ballot items.
Election of 12 directors; Advisory (non-binding) vote to approve executive compensation; Approval of Globe Life Inc. 2026 Incentive Plan (new equity plan and share reserve); Ratification of Deloitte & Touche LLP as independent auditors.
Market cap
$14.3B
1Y TSR
+42.6%
Board grade
B-
Record date
Mar 4, 2026
Filing
DEF 14A
Meeting concluded · Apr 30, 2026
Follow how the vote landed and what changed on Globe Life Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot4
- 1
Election of Directors
ManagementBoard: FORElection of twelve director nominees, each for a one-year term expiring at the 2027 Annual Meeting; nominees include Matthew J. Adams, Cheryl D. Alston, Mark A. Blinn, James P. Brannen, Alice S. Cho, J. Matthew Darden, Philip M. Jacobs, Derek T. Kan, Sandra L. Phillips, David A. Rodriguez, Frank M. Svoboda, and Mary E. Thigpen.
- 2
Advisory Vote on Executive Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the Named Executive Officers as disclosed in the Proxy Statement (Say-on-Pay).
- 3
Approval of Globe Life Inc. 2026 Incentive Plan
ManagementBoard: FORRequest shareholder approval to adopt the Globe Life Inc. 2026 Incentive Plan, authorizing a new share reserve (5,100,000 shares subject to adjustments), fungible share counting, and standard equity award types and governance provisions; aims to replace prior 2018 Plan for future grants.
- 4
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2026.
Director elections
Nominees on the ballot12
Independent
Tenure on this board
8.4 yrs
Independent
Tenure on this board
4.7 yrs
Also a director at
Texas Instruments Inc (TXN)Emerson Electric Co (EMR)Qnity Electronics Inc (Q)
Independent
Tenure on this board
4.7 yrs
Independent
Tenure on this board
3.4 yrs
Also a director at
First Interstate Bancsystem Inc (FIBK)
Not independent
Tenure on this board
3.2 yrs
Independent
Tenure on this board
1.4 yrs
Independent
Tenure on this board
0.4 yrs
Also a director at
Toll Brothers Inc (TOL)Oklo Inc (OKLO)Fortinet Inc (FTNT)
Independent
Tenure on this board
0.4 yrs
Also a director at
Msa Safety Inc (MSA)
Independent
Tenure on this board
3.4 yrs
Not independent
Tenure on this board
3.2 yrs
Independent
Tenure on this board
8.4 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.6% | 5,149,992 | $717M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.5% | 4,254,103 | $592M |
| 3 | STATE STREET CORP | 4.7% | 3,658,664 | $509M |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 3.2% | 2,469,797 | $343M |
| 5 | BlackRock, Inc. | 3.1% | 2,424,349 | $337M |
| 6 | Invesco Ltd. | 3.1% | 2,376,082 | $331M |
| 7 | DIMENSIONAL FUND ADVISORS LP | 2.7% | 2,130,854 | $297M |
| 8 | BlackRock, Inc. | 2.3% | 1,748,611 | $243M |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.8% | 1,402,976 | $195M |
| 10 | Invesco Ltd. | 1.8% | 1,375,654 | $191M |
Peers
Nearest market capOther Financial Services sector meetings6
Upcoming shareholder meetings at Globe Life Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Corebridge Financial IncCRBG
Special meeting·Jul 30, 2026·$14.6B
Equitable Holdings IncEQH
Special meeting·Jul 30, 2026·$13.8B
Ares Capital CorpARCC
Special meeting·Aug 13, 2026·$13.8B
Blackstone Secured Lending FundBXSL
Annual meeting·Sep 24, 2026·$5.5B
Corvel CorpCRVL
Annual meeting·Aug 6, 2026·$3.1B
Hilltop Holdings IncHTH
Annual meeting·Jul 23, 2026·$2.3B
Reference
Frequently asked questions
- When is the Globe Life Inc 2026 annual meeting?
- Globe Life Inc (GL) holds its 2026 annual shareholder meeting on Thursday, April 30, 2026.
- What is the record date for the Globe Life Inc 2026 meeting?
- The record date for the Globe Life Inc 2026 meeting is Wednesday, March 4, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Globe Life Inc's 2026 meeting?
- The board is presenting 12 director nominees at the Globe Life Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Globe Life Inc 2026 meeting?
- Shareholders will vote on 4 proposals at the Globe Life Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.